Mexiletine in the treatment of blepharospasm : Experience with the first three patients
Identifieur interne :
003952 ( PascalFrancis/Curation );
précédent :
003951;
suivant :
003953
Mexiletine in the treatment of blepharospasm : Experience with the first three patients
Auteurs : S. Ohara [
Japon] ;
J. Tsuyuzaki [
Japon] ;
R. Hayashi [
Japon]
Source :
-
Movement disorders [ 0885-3185 ] ; 1999.
RBID : Pascal:99-0086356
Descripteurs français
- Pascal (Inist)
- Blépharospasme,
Dystonie,
Localisé,
Mexilétine,
Chimiothérapie,
Myorésolutif,
Voie orale,
Etude cas,
Traitement,
Adulte,
Mâle,
Femelle.
- Wicri :
English descriptors
- KwdEn :
- Adult,
Blepharospasm,
Case study,
Chemotherapy,
Dystonia,
Female,
Localized,
Male,
Mexiletine,
Muscle relaxant,
Oral administration,
Treatment.
pA |
A01 | 01 | 1 | | @0 0885-3185 |
---|
A03 | | 1 | | @0 Mov. disord. |
---|
A05 | | | | @2 14 |
---|
A06 | | | | @2 1 |
---|
A08 | 01 | 1 | ENG | @1 Mexiletine in the treatment of blepharospasm : Experience with the first three patients |
---|
A11 | 01 | 1 | | @1 OHARA (S.) |
---|
A11 | 02 | 1 | | @1 TSUYUZAKI (J.) |
---|
A11 | 03 | 1 | | @1 HAYASHI (R.) |
---|
A14 | 01 | | | @1 Department of Neurology, National Chushin-Matsumoto Hospital @2 Matsumoto @3 JPN @Z 1 aut. @Z 2 aut. |
---|
A14 | 02 | | | @1 Department of Medicine (Neurology), Shinshu University, School of Medicine @2 Matsumoto @3 JPN @Z 3 aut. |
---|
A20 | | | | @1 173-175 |
---|
A21 | | | | @1 1999 |
---|
A23 | 01 | | | @0 ENG |
---|
A43 | 01 | | | @1 INIST @2 20953 @5 354000073349160320 |
---|
A44 | | | | @0 0000 @1 © 1999 INIST-CNRS. All rights reserved. |
---|
A45 | | | | @0 8 ref. |
---|
A47 | 01 | 1 | | @0 99-0086356 |
---|
A60 | | | | @1 P |
---|
A61 | | | | @0 A |
---|
A64 | | 1 | | @0 Movement disorders |
---|
A66 | 01 | | | @0 USA |
---|
C02 | 01 | X | | @0 002B02C |
---|
C03 | 01 | X | FRE | @0 Blépharospasme @5 01 |
---|
C03 | 01 | X | ENG | @0 Blepharospasm @5 01 |
---|
C03 | 01 | X | SPA | @0 Blefaroespasmo @5 01 |
---|
C03 | 02 | X | FRE | @0 Dystonie @5 04 |
---|
C03 | 02 | X | ENG | @0 Dystonia @5 04 |
---|
C03 | 02 | X | SPA | @0 Distonía @5 04 |
---|
C03 | 03 | X | FRE | @0 Localisé @5 05 |
---|
C03 | 03 | X | ENG | @0 Localized @5 05 |
---|
C03 | 03 | X | SPA | @0 Localizado @5 05 |
---|
C03 | 04 | X | FRE | @0 Mexilétine @2 NK @2 FR @5 07 |
---|
C03 | 04 | X | ENG | @0 Mexiletine @2 NK @2 FR @5 07 |
---|
C03 | 04 | X | SPA | @0 Mexiletina @2 NK @2 FR @5 07 |
---|
C03 | 05 | X | FRE | @0 Chimiothérapie @5 08 |
---|
C03 | 05 | X | ENG | @0 Chemotherapy @5 08 |
---|
C03 | 05 | X | SPA | @0 Quimioterapia @5 08 |
---|
C03 | 06 | X | FRE | @0 Myorésolutif @5 09 |
---|
C03 | 06 | X | ENG | @0 Muscle relaxant @5 09 |
---|
C03 | 06 | X | SPA | @0 Relajante muscular @5 09 |
---|
C03 | 07 | X | FRE | @0 Voie orale @5 10 |
---|
C03 | 07 | X | ENG | @0 Oral administration @5 10 |
---|
C03 | 07 | X | SPA | @0 Vía oral @5 10 |
---|
C03 | 08 | X | FRE | @0 Etude cas @5 17 |
---|
C03 | 08 | X | ENG | @0 Case study @5 17 |
---|
C03 | 08 | X | SPA | @0 Estudio caso @5 17 |
---|
C03 | 09 | X | FRE | @0 Traitement @5 18 |
---|
C03 | 09 | X | ENG | @0 Treatment @5 18 |
---|
C03 | 09 | X | GER | @0 Aufbereiten @5 18 |
---|
C03 | 09 | X | SPA | @0 Tratamiento @5 18 |
---|
C03 | 10 | X | FRE | @0 Adulte @5 20 |
---|
C03 | 10 | X | ENG | @0 Adult @5 20 |
---|
C03 | 10 | X | SPA | @0 Adulto @5 20 |
---|
C03 | 11 | X | FRE | @0 Mâle @5 21 |
---|
C03 | 11 | X | ENG | @0 Male @5 21 |
---|
C03 | 11 | X | SPA | @0 Macho @5 21 |
---|
C03 | 12 | X | FRE | @0 Femelle @5 22 |
---|
C03 | 12 | X | ENG | @0 Female @5 22 |
---|
C03 | 12 | X | SPA | @0 Hembra @5 22 |
---|
C07 | 01 | X | FRE | @0 Homme |
---|
C07 | 01 | X | ENG | @0 Human |
---|
C07 | 01 | X | SPA | @0 Hombre |
---|
C07 | 02 | X | FRE | @0 Oeil pathologie @5 37 |
---|
C07 | 02 | X | ENG | @0 Eye disease @5 37 |
---|
C07 | 02 | X | SPA | @0 Ojo patología @5 37 |
---|
C07 | 03 | X | FRE | @0 Paupière pathologie @5 38 |
---|
C07 | 03 | X | ENG | @0 Eyelid disease @5 38 |
---|
C07 | 03 | X | SPA | @0 Párpado patología @5 38 |
---|
C07 | 04 | X | FRE | @0 Muscle strié pathologie @5 45 |
---|
C07 | 04 | X | ENG | @0 Striated muscle disease @5 45 |
---|
C07 | 04 | X | SPA | @0 Músculo estriado patología @5 45 |
---|
C07 | 05 | X | FRE | @0 Système nerveux pathologie @5 46 |
---|
C07 | 05 | X | ENG | @0 Nervous system diseases @5 46 |
---|
C07 | 05 | X | SPA | @0 Sistema nervioso patología @5 46 |
---|
C07 | 06 | X | FRE | @0 Trouble neurologique @5 47 |
---|
C07 | 06 | X | ENG | @0 Neurological disorder @5 47 |
---|
C07 | 06 | X | SPA | @0 Trastorno neurológico @5 47 |
---|
C07 | 07 | X | FRE | @0 Mouvement involontaire @5 48 |
---|
C07 | 07 | X | ENG | @0 Involuntary movement @5 48 |
---|
C07 | 07 | X | SPA | @0 Movimiento involuntario @5 48 |
---|
C07 | 08 | X | FRE | @0 Extrapyramidal syndrome @5 49 |
---|
C07 | 08 | X | ENG | @0 Extrapyramidal syndrome @5 49 |
---|
C07 | 08 | X | SPA | @0 Extrapiramidal síndrome @5 49 |
---|
N21 | | | | @1 046 |
---|
|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002E72
Links to Exploration step
Pascal:99-0086356
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Mexiletine in the treatment of blepharospasm : Experience with the first three patients</title>
<author><name sortKey="Ohara, S" sort="Ohara, S" uniqKey="Ohara S" first="S." last="Ohara">S. Ohara</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, National Chushin-Matsumoto Hospital</s1>
<s2>Matsumoto</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Tsuyuzaki, J" sort="Tsuyuzaki, J" uniqKey="Tsuyuzaki J" first="J." last="Tsuyuzaki">J. Tsuyuzaki</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, National Chushin-Matsumoto Hospital</s1>
<s2>Matsumoto</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Hayashi, R" sort="Hayashi, R" uniqKey="Hayashi R" first="R." last="Hayashi">R. Hayashi</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Medicine (Neurology), Shinshu University, School of Medicine</s1>
<s2>Matsumoto</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0086356</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0086356 INIST</idno>
<idno type="RBID">Pascal:99-0086356</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002E72</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003952</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Mexiletine in the treatment of blepharospasm : Experience with the first three patients</title>
<author><name sortKey="Ohara, S" sort="Ohara, S" uniqKey="Ohara S" first="S." last="Ohara">S. Ohara</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, National Chushin-Matsumoto Hospital</s1>
<s2>Matsumoto</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Tsuyuzaki, J" sort="Tsuyuzaki, J" uniqKey="Tsuyuzaki J" first="J." last="Tsuyuzaki">J. Tsuyuzaki</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, National Chushin-Matsumoto Hospital</s1>
<s2>Matsumoto</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Hayashi, R" sort="Hayashi, R" uniqKey="Hayashi R" first="R." last="Hayashi">R. Hayashi</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Medicine (Neurology), Shinshu University, School of Medicine</s1>
<s2>Matsumoto</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Blepharospasm</term>
<term>Case study</term>
<term>Chemotherapy</term>
<term>Dystonia</term>
<term>Female</term>
<term>Localized</term>
<term>Male</term>
<term>Mexiletine</term>
<term>Muscle relaxant</term>
<term>Oral administration</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Blépharospasme</term>
<term>Dystonie</term>
<term>Localisé</term>
<term>Mexilétine</term>
<term>Chimiothérapie</term>
<term>Myorésolutif</term>
<term>Voie orale</term>
<term>Etude cas</term>
<term>Traitement</term>
<term>Adulte</term>
<term>Mâle</term>
<term>Femelle</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adulte</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA08 i1="01" i2="1" l="ENG"><s1>Mexiletine in the treatment of blepharospasm : Experience with the first three patients</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>OHARA (S.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>TSUYUZAKI (J.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>HAYASHI (R.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, National Chushin-Matsumoto Hospital</s1>
<s2>Matsumoto</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Medicine (Neurology), Shinshu University, School of Medicine</s1>
<s2>Matsumoto</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s1>173-175</s1>
</fA20>
<fA21><s1>1999</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000073349160320</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1999 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>8 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>99-0086356</s0>
</fA47>
<fA64 i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02C</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Blépharospasme</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Blepharospasm</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Blefaroespasmo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Dystonie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Dystonia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Distonía</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Localisé</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Localized</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Localizado</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Mexilétine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Mexiletine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Mexiletina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Myorésolutif</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Muscle relaxant</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Relajante muscular</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Voie orale</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Oral administration</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Vía oral</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Etude cas</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Case study</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Estudio caso</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Traitement</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Treatment</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="GER"><s0>Aufbereiten</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Adulte</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Adult</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Adulto</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Mâle</s0>
<s5>21</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Male</s0>
<s5>21</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Macho</s0>
<s5>21</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Femelle</s0>
<s5>22</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Female</s0>
<s5>22</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Hembra</s0>
<s5>22</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Oeil pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Eye disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Ojo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Paupière pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Eyelid disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Párpado patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Muscle strié pathologie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Striated muscle disease</s0>
<s5>45</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Músculo estriado patología</s0>
<s5>45</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>46</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>46</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>46</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>47</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>47</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>47</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>48</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>48</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>48</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>49</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>49</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>49</s5>
</fC07>
<fN21><s1>046</s1>
</fN21>
</pA>
</standard>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003952 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 003952 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:99-0086356
|texte= Mexiletine in the treatment of blepharospasm : Experience with the first three patients
}}
| This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 | ![](Common/icons/LogoDilib.gif) |